Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06254924 · ClinicalTrials.gov registry record · NA

Qoyangnuptu: Qoyangnuptu Intervention (QI) App

A NA study of Mental Health Wellness 1, sponsored by Northern Arizona University.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06254924: Recruiting NA study of Mental Health Wellness 1, sponsored by Northern Arizona University.

NCT06254924 is a NA study of Mental Health Wellness 1 that is actively recruiting participants, run by Northern Arizona University. The registered enrollment target is 24 participants, below the 728-participant average among 20 other Mental Health Wellness 1 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06254924, a NA study of Mental Health Wellness 1, is actively recruiting participants, sponsored by Northern Arizona University.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn about the impacts of using a mobile health app, the Qoyangnuptu Intervention App (QI App) a Southwestern Tribal Community. The main questions it aims to answer are: In American Indian/Alaska Native communities with unique cultural characteristics, how should a youth-focused sociotechnical behavioral health intervention be designed to encourage sustained engagement and positively impact indicators of behavioral health?; How can interactive technical interventions be designed to best support sustained community engagement in a challenged network environment? Participants will: * Receive daily guidance and encouragement to use the app from an anonymous, trained peer mentor * Be able to ask their peer mentors questions in a monitored one-on-one chat in the QI app or in a monitored group chat in the QI app * Log their mood and stress level on the app once per day * Practice mindfulness skills as directed in the QI app, including guided breathing, meditation, drawing, coloring, and walking * Practice Hopi cultural activities like running using the QI app to help track progress towards team mileage goals

Primary Outcome

Through qualitative interviews, the investigators will determine the acceptability of the QI App. 12 participants will be interviewed after they have used the app for 6 weeks.

Conditions Studied

Interventions

  • BEHAVIORAL QI App Users
  • BEHAVIORAL Parents/Guardians of QI App Users

Study Locations (1)

Arizona

  • Northern Arizona University - Flagstaff

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-08-30
Est. Completion 2026-10-01
Phase NA
Northern Arizona University

23 total trials

What NCT06254924 shows while recruiting

NCT06254924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 728-participant average among 20 other Mental Health Wellness 1 trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Mental Health Wellness 1 appearing as the primary indexed condition, and to 2 interventions - of which QI App Users is the first listed.

NCT06254924 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT06254924 about?

NCT06254924 is a clinical study titled "Qoyangnuptu: Qoyangnuptu Intervention (QI) App". The goal of this clinical trial is to learn about the impacts of using a mobile health app, the Qoyangnuptu Intervention App (QI App) a Southwestern Tribal Community. The main questions it aims to answer are: In American Indian/Alaska Native communities with unique cultural characteristics, how sho...

What is the current status of trial NCT06254924?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-08-30. Estimated completion is 2026-10-01.

What conditions does trial NCT06254924 study?

This clinical trial studies the following conditions: Mental Health Wellness 1.

What interventions are being tested in trial NCT06254924?

The interventions under investigation include: QI App Users (BEHAVIORAL), Parents/Guardians of QI App Users (BEHAVIORAL).

Who is sponsoring clinical trial NCT06254924?

This trial is sponsored by Northern Arizona University, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06254924 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Health Wellness 1

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06254924's enrollment target sits among peer trials

24 19th of 20 higher than 2 of 20 other Mental Health Wellness 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Health Wellness 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06254924, the US trial registry maintained by the National Library of Medicine. NCT06254924 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.